Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen’s Longer-Lasting MS Drug Meets Goals in Late Trial
Biogen’s Longer-Lasting MS Drug Meets Goals in Late Trial
Biogen’s Longer-Lasting MS Drug Meets Goals in Late Trial
Submitted by
admin
on January 24, 2013 - 10:33am
Source:
Bloomberg
News Tags:
MS
Biogen Idec
multiple sclerosis
peginterferon beta-1a
Headline:
Biogen’s Longer-Lasting MS Drug Meets Goals in Late Trial
Do Not Allow Advertisers to Use My Personal information
